A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial.
Zhang Y, Zhang J, Yi H, Zheng J, Cai J, Chen W, Lu T, Chen L, Du C, Liu J, Yao J, Zhao H, Wang G, Fu B, Zhang T, Zhang J, Wang G, Li H, Xiang AP, Chen G, Yi S, Zhang Q, Yang Y.
Zhang Y, et al. Among authors: chen l, chen w, chen g.
Stem Cell Res Ther. 2021 Apr 16;12(1):244. doi: 10.1186/s13287-021-02246-4.
Stem Cell Res Ther. 2021.
PMID: 33863383
Free PMC article.
Clinical Trial.